← Back to Analyst Consensus 
MDLN Buy
Medline Inc.
Current Price —
Implied Upside —
Analysts 34
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 2 reiterations from 2 firms
Next Earnings
Nov 4, 2026 (9 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 22, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Oct 9, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Sep 25, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Aug 27, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Aug 12, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Aug 11, 2026 | Tigress Financial | maintain | Buy → Buy | — | 55% |
| Aug 11, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Aug 10, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Aug 6, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Aug 6, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Aug 6, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Aug 6, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Jul 31, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Jun 3, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| Jun 1, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| May 14, 2026 | BNP Paribas | maintain | Neutral → Neutral | — | 51% |
| May 13, 2026 | Tigress Financial | maintain | Buy → Buy | — | 55% |
| May 7, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| May 7, 2026 | Bernstein | maintain | Outperform → Outperform | — | 52% |
| May 7, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Mar 10, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Mar 9, 2026 | Tigress Financial | maintain | Buy → Buy | — | 55% |
| Mar 9, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Mar 2, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Feb 27, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $47 | 54% |
| Feb 26, 2026 | Citigroup | maintain | Buy → Buy | $60 | 54% |
| Feb 26, 2026 | UBS | maintain | Buy → Buy | $57 | 54% |
| Feb 26, 2026 | BMO Capital | maintain | Outperform → Outperform | $54 | 53% |
| Feb 26, 2026 | RBC Capital | maintain | Outperform → Outperform | $53 | 55% |
| Feb 26, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | $55 | 58% |
| Feb 5, 2026 | Tigress Financial | initiate | — → Buy | $55 | 55% |
| Jan 12, 2026 | Citigroup | initiate | — → Buy | $48 | 54% |
| Jan 12, 2026 | Stifel | initiate | — → Buy | $46 | 53% |
| Jan 12, 2026 | Goldman Sachs | initiate | — → Buy | $49 | 54% |
| Jan 12, 2026 | Deutsche Bank | initiate | — → Hold | $40 | 57% |
| Jan 12, 2026 | Wolfe Research | initiate | — → Outperform | $47 | 53% |
| Jan 12, 2026 | Barclays | initiate | — → Overweight | $50 | 53% |
| Jan 12, 2026 | Wells Fargo | initiate | — → Equal-Weight | $42 | 54% |
| Jan 12, 2026 | BMO Capital | initiate | — → Outperform | $45 | 53% |
| Jan 12, 2026 | Evercore ISI Group | initiate | — → Outperform | $50 | 58% |
| Jan 12, 2026 | UBS | initiate | — → Buy | $48 | 54% |
| Jan 12, 2026 | Truist Securities | initiate | — → Buy | $52 | 54% |
| Jan 12, 2026 | Piper Sandler | initiate | — → Overweight | $50 | 54% |
| Jan 12, 2026 | Mizuho | initiate | — → Outperform | $48 | 52% |
| Jan 12, 2026 | Morgan Stanley | initiate | — → Overweight | $48 | 54% |
| Jan 12, 2026 | Leerink Partners | initiate | — → Outperform | $48 | 51% |
| Jan 12, 2026 | TD Cowen | initiate | — → Buy | $46 | 54% |
| Jan 12, 2026 | Baird | initiate | — → Outperform | $48 | 55% |
| Jan 12, 2026 | JP Morgan | initiate | — → Overweight | $50 | 54% |
| Jan 12, 2026 | RBC Capital | initiate | — → Outperform | $47 | 55% |
Price Target Trend
Jul 23, 2026 Oct 26, 2026
EPS Estimates
+1q —
0y —
0q —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days